Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.18 | 58.61 |
PEG Ratio (TTM) | 0.00 | 1.56 |
P/S Ratio (TTM) | 1.30 | 4.50 |
P/B Ratio (TTM) | 1.78 | 4.10 |
P/FCF Ratio (TTM) | -1.12 | -8.02 |
Price to 5YR AVG Earnings Ratio | N/A | 40.74 |
Price to 5YR AVG FCF Ratio | N/A | -12.46 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -51.45% | 4.18% |
ROE (TTM) | -103.85% | 117.02% |
Net Profit Margin (TTM) | -110.29% | -55.66% |
ROIC 5YR AVG | N/A | -0.51% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -35.45% | -110,076.77% | N/A |
Revenue | 0.44% | 39.15% | N/A |
Net Income | -35.75% | -82,495.34% | N/A |
Cash Flow | -433.24% | -95,637.24% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.96 | 2.49 |
Quick Ratio (TTM) | 1.60 | 1.92 |
D/E Ratio (TTM) | 1.14 | 0.64 |
Interest Coverage (TTM) | -3.63 | 33.23 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 3.60 |
LTL to 5YR AVG FCF | N/A | -0.38 |
Shares Outstanding Growth 5YR AVG | N/A | 5.80% |